The Impact of HAART on Response to Hepatitis C Treatment in Patients Taking Peginterferon Alpha-2b and Ribavirin
Clinical trial NCT00031343 · COMPLETED
Trial details
- NCT number
- NCT00031343
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-02-01
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.